MSB7528.jpg

MSB7518.jpg

MSB7527.jpg

MSB7537.jpg

MSB7525.jpg

MSB7526.jpg

MSB7515.jpg

MSB7519.jpg

MSB7543.jpg

MSB7529.jpg

May 15, 2014

 

Although tuberculosis (TB) is preventable and curable, it is the second-biggest infectious disease killer behind HIV and claims nearly 1.3 million lives each year.

The spread of drug-resistant strains of the disease is increasingly recognized as a public health emergency. Drug-resistant tuberculosis (DR-TB) is an umbrella term that refers to tuberculosis strains which resist the drugs routinely used to treat conventional TB.

The term DR-TB includes multidrug-resistant TB (MDR-TB), where the patient is resistant to two of the most effective tuberculosis medicines, and extensively drug-resistant TB (XDR-TB), which is even harder to cure.

This photo gallery offers a glimpse into the world of DR-TB patients and staff at an MSF clinic in Mumbai, India. Treatment is long, complex, and painful, with severe side effects.

At the 2014 World Health Assembly in Geneva, Switzerland, former XDR-TB patient Phumeza Tisile of South Africa is calling attention to MSF’s demands for progress against this epidemic. She will deliver the 'Test Me, Treat Me' DR-TB Manifesto and its call to action—supported by tens of thousands of patients, medical practitioners, and advocates—directly to delegates as they discuss the next 20-year global plan to control tuberculosis.  

For more information, visit the “Test Me, Treat Me” DR-TB Manifesto campaign website: https://www.msfaccess.org/TBmanifesto/

*Patients’ names have been changed to protect their privacy.

Related News & Publications

Be part of MSF

Our supporters, donors and fundraisers are a vital part of the MSF movement.

Find out how you can support MSF's lifesaving work.

Learn more